UNRESECTABLE UROTHELIAL CARCINOMA
Clinical trials for UNRESECTABLE UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Step attack on advanced bladder cancer
Disease control Recruiting nowThis study is testing a two-part treatment for people with advanced bladder cancer that has spread. First, patients receive a combination of two drugs for about 4 months. If the cancer responds, they then continue with one of the drugs as a long-term 'maintenance' therapy for up …
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test new weapon against Tough-to-Treat bladder cancer
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a new two-drug combination for people with advanced bladder cancer that has spread and no longer responds to standard immunotherapy. The trial combines an experimental pill (CA-4948) with an existing immunotherapy drug…
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Custom cancer vaccine designed to train your own immune system
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to teach the body's immune system to recognize and attack a patient's specific cancer. It is being given alongside an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that have spread. The …
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Cancer care comes home: trial tests if shots at home beat clinic visits
Disease control Recruiting nowThis study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and time spent in medical facilities, pote…
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for Tough-to-Treat bladder cancer: major trial tests promising drug duo
Disease control Recruiting nowThis study is for people with advanced bladder cancer that has spread and has stopped responding to a common type of immunotherapy. It aims to see if a new combination of two drugs (pembrolizumab and sacituzumab govitecan) works better and helps people live longer than the curren…
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug duo tested in Tough-to-Treat bladder cancer
Disease control Recruiting nowThis early-stage study is testing a combination of two drugs, cabozantinib and enfortumab vedotin, for advanced bladder cancer that has spread. The main goal is to find the safest and most effective dose. The study will also look for early signs that the treatment can shrink tumo…
Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC